Valuation: Ha Tay Pharmaceutical

Market Cap 5,860B 223M 195M 180M 167M 316M 21.15B 321M 2.16B 838M 10.44B 837M 819M 36.08B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,959B 227M 198M 183M 169M 322M 21.51B 327M 2.19B 852M 10.62B 851M 832M 36.69B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+0.94%
1 week-1.97%
Current month-0.46%
1 month-1.52%
3 months-4.99%
6 months-4.99%
Current year-7.57%
1 week 62,500
Extreme 62500
66,000
1 month 60,600
Extreme 60600
70,000
Current year 60,600
Extreme 60600
75,800
1 year 60,600
Extreme 60600
86,800
3 years 17,090.91
Extreme 17090.9091
100,818.18
5 years 11,980.52
Extreme 11980.5195
100,818.18
10 years 4,594.65
Extreme 4594.6478
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 2016-03-31
Corporate Officer/Principal - 2016-02-29
Corporate Officer/Principal 49 2015-02-03
Director TitleAgeSince
Chairman 75 2015-12-31
Director/Board Member 53 -
Director/Board Member 62 2013-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%-1.97%-13.73%+184.68% 221M
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+0.45%+1.65%+25.65%+68.35% 198B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
Average +0.86%+1.52%+22.87%+66.59% 346.77B
Weighted average by Cap. +1.50%+1.63%+41.84%+87.35%

Financials

2024 2025
Net sales 2,086B 79.35M 69.44M 63.99M 59.31M 113M 7.53B 114M 767M 298M 3.72B 298M 291M 12.85B 2,402B 91.35M 79.94M 73.68M 68.29M 130M 8.67B 132M 883M 344M 4.28B 343M 336M 14.79B
Net income 71.77B 2.73M 2.39M 2.2M 2.04M 3.87M 259M 3.94M 26.4M 10.27M 128M 10.25M 10.03M 442M 53.66B 2.04M 1.79M 1.65M 1.53M 2.9M 194M 2.94M 19.73M 7.67M 95.58M 7.66M 7.5M 330M
Net Debt 290B 11.03M 9.65M 8.89M 8.24M 15.65M 1.05B 15.9M 107M 41.47M 516M 41.39M 40.5M 1.79B 98.73B 3.75M 3.29M 3.03M 2.81M 5.33M 356M 5.41M 36.31M 14.12M 176M 14.1M 13.79M 608M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
26-07-07 ₫64,700.00 +0.94% 20,111
26-07-06 ₫64,100.00 -0.62% 133
26-07-03 ₫64,500.00 0.00% 19,701
26-07-02 ₫64,500.00 0.00% 6,003
26-07-01 ₫64,500.00 -0.77% 1,200